Targeting mitochondrial DNA with a platinum-based anticancer agent. - Wikidata - wikimedia - TriplyDB

Targeting mitochondrial DNA with a platinum-based anticancer agent.

Targeting mitochondrial DNA with a platinum-based anticancer agent.

http://www.wikidata.org/entity/Q33847450

about

Mitochondrial DNA Damage and Diseases The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs An integrated view of cisplatin-induced nephrotoxicity and ototoxicity The pharmacokinetic study of sinomenine, paeoniflorin and paeonol in rats after oral administration of a herbal product Qingfu Guanjiesu capsule by HPLC.Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions.Detouring of cisplatin to access mitochondrial genome for overcoming resistance Poisoning of mitochondrial topoisomerase I by lamellarin D Peptide Targeting of Fluorescein-Based Sensors to Discrete Intracellular Locales.Targeted nanoparticles in mitochondrial medicine.Mitochondria-penetrating peptides conjugated to desferrioxamine as chelators for mitochondrial labile iron Cisplatin Analogs Confer Protection against Cyanide Poisoning.Nanotechnology inspired tools for mitochondrial dysfunction related diseases.Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.Targeting mitochondrial function for the treatment of breast cancer.Nanoparticle approaches to combating drug resistance.Target-selective delivery and activation of platinum-based anticancer agents.Derivatisation of buforin IIb, a cationic henicosapeptide, to afford its complexation to platinum(ii) resulting in a novel platinum(ii)-buforin IIb conjugate with anti-cancer activity.Unique Use of Alkylation for Chemo-Redox Activity by a Pt(IV) Prodrug.Mitochondria: Inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting?Mitochondrial DNA damage by bleomycin induces AML cell death.The Platin-X series: activation, targeting, and delivery.Mitochondrially targeted fluorescent redox sensors.Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.Construction and application of a Rh-Pt DNA metalloinsertor conjugate.Platinum-RNA modifications following drug treatment in S. cerevisiae identified by click chemistry and enzymatic mapping.Targeted Chemotherapy with Metal Complexes.Mitochondria-targeted platinum(ii) complexes: dual inhibitory activities on tumor cell proliferation and migration/invasion via intracellular trafficking of β-catenin.Functional Mitochondria in Health and Disease.Oxovanadium(IV) complexes of curcumin for cellular imaging and mitochondria targeted photocytotoxicity.Inhibition of Mitochondrial Division Attenuates Cisplatin-Induced Toxicity in the Neuromast Hair Cells.Mitochondrial DNA repair and replication proteins revealed by targeted chemical probes.Organometallic Rhenium Complexes Divert Doxorubicin to the Mitochondria.Targeting cancer cell metabolism with mitochondria-immobilized phosphorescent cyclometalated iridium(iii) complexes.Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment

P2860

Q27007991-C7C8D3DA-8546-4A4B-9553-92690F646E5B Q28066801-E8A81F41-71BE-41D4-A137-6F15459B2583 Q28080615-069C5C57-35AB-4CC6-9BD0-7353C9724D98 Q31153864-880D6A7E-3A8D-4189-ACFD-39D169355B1F Q33798999-A365F7EC-BEB3-430D-A4B2-9505504E5C3E Q33972195-4F105683-6D6F-49DB-9758-1E61BD5586A6 Q34024641-BA1A4ECA-6065-4052-BE2D-B4F16F0B4429 Q34688362-3464F02E-2E3F-497B-8D28-DFB6AD1AC388 Q35417165-FACDAA1E-8789-4B38-87E2-28427172CED6 Q36274297-185D1634-768A-4887-98FC-21E28529487A Q36349055-00147729-EE77-4CC8-A37A-8A831371DE29 Q36703351-A5404D2C-FE88-4298-B5C8-20BB09EC61AD Q37498914-D81FA020-0FBF-46FA-8189-AF8F4192FA77 Q38264534-2AADDEE1-8599-4703-9E6E-D957F4D62572 Q38422748-9D300C50-0638-4EBB-A4DE-2F02A34D4EA0 Q38523600-65914BD0-0F4C-4D8F-BBA2-653E552E5161 Q38764873-BFB2AA9D-146A-42D0-8BFD-F8F70B9D2045 Q38799693-4D160528-8862-48E2-B522-F3ED7ED1C673 Q38831900-8DC5DCA1-117C-42A7-8BB2-3F6A7BD31D36 Q38893580-35515FF1-0438-466B-A327-3483597638F5 Q38919253-458DBBBF-1606-4B19-AF71-7624CFA5EE31 Q39223391-08E7C403-3E00-454F-AC35-977449C0A0FB Q39400621-625F8CFF-01D4-4E6F-B420-2411086A9F74 Q42773508-41A7318F-BF2F-42D1-B292-C83B8169E343 Q42949446-9D6BC705-01F6-4740-9B1E-0B9DBA42D551 Q43122076-4CF176A2-C9E7-4054-A758-568EA099E231 Q46364644-66207E5C-B038-489E-AC58-9528C620CA52 Q46562647-4D6AB396-8B36-459B-81CD-8105728C302A Q46860046-9F9F9470-7BBC-4711-AA5C-36EFA80C1C40 Q47194882-32CE6A22-26DE-4597-ABA6-DB507EAAB5C3 Q48219294-D7E830B0-EB04-4A67-91F6-32EEB2D52509 Q53800492-151AAC05-6AF5-48BE-9005-538255D7F755 Q55315187-AC923A21-9B04-4302-9D36-C33BB580BBC0 Q58769558-0B1ADF2C-B3CA-4699-8A55-51BF0DF816A8

P2860

Targeting mitochondrial DNA with a platinum-based anticancer agent.

http://www.wikidata.org/entity/Q33847450

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Targeting mitochondrial DNA with a platinum-based anticancer agent.

@ast

Targeting mitochondrial DNA with a platinum-based anticancer agent.

@en

type

label

Targeting mitochondrial DNA with a platinum-based anticancer agent.

@ast

Targeting mitochondrial DNA with a platinum-based anticancer agent.

@en

prefLabel

Targeting mitochondrial DNA with a platinum-based anticancer agent.

@ast

Targeting mitochondrial DNA with a platinum-based anticancer agent.

@en

P1433

Q33847450-CB9B12F5-F63A-4D68-A845-135C0B833917

P1476

Q33847450-E3056D19-E928-4D47-BB49-5F6A5AD4A30C

P2093

Q33847450-0762DAD2-CB15-415B-B393-D731EB274BCA

Q33847450-262E72CA-2BFD-4AFC-8DB8-6FDDA0FA7F9A

Q33847450-3EBD74B6-D7A7-435C-918A-213F8EB230AA

Q33847450-BE26DAF8-B2EB-45B7-8313-FCC7BE1B4AAD

Q33847450-D7A7A45C-7FDA-4EF3-B256-0A4E2FB65FD8

P2860

Q33847450-02D87861-2428-4CA1-8161-45BCAD0F9EDE

Q33847450-26F6A2CE-20C5-409D-A12F-2056ACC882C5

Q33847450-2C8DE6CA-4415-4E6C-B38B-A2A72CCC6043

Q33847450-3D5782EC-3897-462F-8464-1FF40EDCDC0C

Q33847450-691ED95B-29D9-451C-B9CE-A7D37E0B8BAA

Q33847450-69815604-F363-42ED-96D9-F8F1294168C2

Q33847450-6A328608-444B-4A88-BD03-6DDB6E5C6108

Q33847450-81304110-3BB0-4EA4-A765-5934EDBC9B57

Q33847450-887E0212-BAA1-49BB-8D01-C531228B7B24

Q33847450-93DD65E4-E576-4870-8D2D-DE694ADEFD3A

P304

Q33847450-F015BF8A-A97F-4673-B26E-FF34524376DD

P31

Q33847450-20883C70-9E8A-4AA7-A1EC-C722281D26D8

P356

Q33847450-EE19099C-0D91-4F7A-8FAE-85645E886977

P433

Q33847450-9A5E0C22-A434-4EC4-99AE-80F5705BD702

P478

Q33847450-2880AD62-977A-4933-BFBD-EAC63762E254

P50

Q33847450-0BC52975-689F-4F51-93F3-2C68A80767CF

Q33847450-1D3BDBA0-4583-4D48-BE68-D4C463FE2E0E

Q33847450-33FD2EA7-7A03-4956-9499-26AF4B8E18A4

P577

Q33847450-CDDAD7E9-A6C1-4245-997A-567CF50E07A5

P5875

Q33847450-0961FBA2-18F3-4D7B-ABBE-EB4723A345AA

P698

Q33847450-697A7D22-F5CA-4452-B515-AC546BE3F065

P921

Q33847450-AC543B15-17BE-45A1-9EC8-982C07EC6A1F

P932

Q33847450-8544544F-3049-46D5-A90B-0D3EF3A2B79A

P356

J.CHEMBIOL.2013.08.010

P1433

Chemistry and Biology

P1476

Targeting mitochondrial DNA with a platinum-based anticancer agent.

@en

P2093

Maria R Chan

http://www.w3.org/2001/XMLSchema#string

Mark P Pereira

http://www.w3.org/2001/XMLSchema#string

Rebecca R Laposa

http://www.w3.org/2001/XMLSchema#string

Robert J Radford

http://www.w3.org/2001/XMLSchema#string

Simon P Wisnovsky

http://www.w3.org/2001/XMLSchema#string

P2860

NIH Image to ImageJ: 25 years of image analysis

Re-directing an alkylating agent to mitochondria alters drug target and cell death mechanism

Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging

Mitochondria in platinum resistant cells.

Peptide targeting of platinum anti-cancer drugs

Targeting mitochondria for cancer therapy.

Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation.

Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells

In vitro anticancer activity of cis-diammineplatinum(II) complexes with β-diketonate leaving group ligands

Update of the preclinical situation of anticancer platinum complexes: novel design strategies and innovative analytical approaches.

P304

1323-1328

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CHEMBIOL.2013.08.010

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Shana O. Kelley

Justin J. Wilson

Stephen J. Lippard

P577

2013-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258252049

http://www.w3.org/2001/XMLSchema#string

P698

24183971

http://www.w3.org/2001/XMLSchema#string

P921

mitochondrial DNA

P932

4082333

http://www.w3.org/2001/XMLSchema#string